Skip to main content

Table 5 Path analysis of models 1, 2, and 3 for monotherapy and adjunctive therapy trials

From: Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials

Model

Monotherapy β (p-value)

Adjunctive therapy β (p-value)

Model 1

β1 = 0.45 (p < 0.001)

β1 = 0.28 (p < 0.05)

Model 2

β2 = −0.41 (p < 0.01)

β2 = −0.36 (p < 0.01)

Model 3

β3 = −0.77(p < 0.001)

β3 = −0.75 (p < 0.001)